This article explores the use of testosterone replacement therapy (TRT) in men with prostate cancer, emphasizing the risks and benefits of its use. It finds that TRT can lead to increased PSA levels, potentially signaling cancer progression. The study highlights the importance of careful monitoring during treatment, as elevated PSA
